169 related articles for article (PubMed ID: 37907046)
1. Differential roles of regulatory T cells in Alzheimer's disease.
Jafarzadeh A; Sheikhi A; Jafarzadeh Z; Nemati M
Cell Immunol; 2023; 393-394():104778. PubMed ID: 37907046
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer's disease.
Faridar A; Vasquez M; Thome AD; Yin Z; Xuan H; Wang JH; Wen S; Li X; Thonhoff JR; Zhao W; Zhao H; Beers DR; Wong STC; Masdeu JC; Appel SH
Acta Neuropathol Commun; 2022 Sep; 10(1):144. PubMed ID: 36180898
[TBL] [Abstract][Full Text] [Related]
3. Regulatory T cells decrease C3-positive reactive astrocytes in Alzheimer-like pathology.
Stym-Popper G; Matta K; Chaigneau T; Rupra R; Demetriou A; Fouquet S; Dansokho C; Toly-Ndour C; Dorothée G
J Neuroinflammation; 2023 Mar; 20(1):64. PubMed ID: 36890536
[TBL] [Abstract][Full Text] [Related]
4. The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer's disease pathology models.
Lantz MJ; Roberts AM; Delgado DD; Nichols RA
J Neuroinflammation; 2023 May; 20(1):129. PubMed ID: 37245024
[TBL] [Abstract][Full Text] [Related]
5. A Therapeutic Nanovaccine that Generates Anti-Amyloid Antibodies and Amyloid-specific Regulatory T Cells for Alzheimer's Disease.
Jung M; Lee S; Park S; Hong J; Kim C; Cho I; Sohn HS; Kim K; Park IW; Yoon S; Kwon S; Shin J; Lee D; Kang M; Go S; Moon S; Chung Y; Kim Y; Kim BS
Adv Mater; 2023 Jan; 35(3):e2207719. PubMed ID: 36329674
[TBL] [Abstract][Full Text] [Related]
6. Morphofunctional Investigation in a Transgenic Mouse Model of Alzheimer's Disease: Non-Reactive Astrocytes Are Involved in Aβ Load and Reactive Astrocytes in Plaque Build-Up.
Lana D; Branca JJV; Delfino G; Giovannini MG; Casamenti F; Nardiello P; Bucciantini M; Stefani M; Zach P; Zecchi-Orlandini S; Nosi D
Cells; 2023 Sep; 12(18):. PubMed ID: 37759482
[TBL] [Abstract][Full Text] [Related]
7. Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics.
Thakur S; Dhapola R; Sarma P; Medhi B; Reddy DH
Inflammation; 2023 Feb; 46(1):1-17. PubMed ID: 35986874
[TBL] [Abstract][Full Text] [Related]
8. Microglia receptors and their implications in the response to amyloid β for Alzheimer's disease pathogenesis.
Doens D; Fernández PL
J Neuroinflammation; 2014 Mar; 11():48. PubMed ID: 24625061
[TBL] [Abstract][Full Text] [Related]
9. Adoptive therapy with amyloid-β specific regulatory T cells alleviates Alzheimer's disease.
Yang H; Park SY; Baek H; Lee C; Chung G; Liu X; Lee JH; Kim B; Kwon M; Choi H; Kim HJ; Kim JY; Kim Y; Lee YS; Lee G; Kim SK; Kim JS; Chang YT; Jung WS; Kim KH; Bae H
Theranostics; 2022; 12(18):7668-7680. PubMed ID: 36451854
[No Abstract] [Full Text] [Related]
10. Glial Cell-Mediated Neuroinflammation in Alzheimer's Disease.
Al-Ghraiybah NF; Wang J; Alkhalifa AE; Roberts AB; Raj R; Yang E; Kaddoumi A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142483
[TBL] [Abstract][Full Text] [Related]
11. Glial cells in Alzheimer's disease: From neuropathological changes to therapeutic implications.
Uddin MS; Lim LW
Ageing Res Rev; 2022 Jun; 78():101622. PubMed ID: 35427810
[TBL] [Abstract][Full Text] [Related]
12. Microglia-Astrocyte Communication in Alzheimer's Disease.
Wu Y; Eisel ULM
J Alzheimers Dis; 2023; 95(3):785-803. PubMed ID: 37638434
[TBL] [Abstract][Full Text] [Related]
13. Influenza vaccination in early Alzheimer's disease rescues amyloidosis and ameliorates cognitive deficits in APP/PS1 mice by inhibiting regulatory T cells.
Yang Y; He Z; Xing Z; Zuo Z; Yuan L; Wu Y; Jiang M; Qi F; Yao Z
J Neuroinflammation; 2020 Feb; 17(1):65. PubMed ID: 32075657
[TBL] [Abstract][Full Text] [Related]
14. Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer's disease.
Singh D
J Neuroinflammation; 2022 Aug; 19(1):206. PubMed ID: 35978311
[TBL] [Abstract][Full Text] [Related]
15. Role of Microglia and Astrocytes in Alzheimer's Disease: From Neuroinflammation to Ca
Di Benedetto G; Burgaletto C; Bellanca CM; Munafò A; Bernardini R; Cantarella G
Cells; 2022 Sep; 11(17):. PubMed ID: 36078138
[TBL] [Abstract][Full Text] [Related]
16. Glia-Driven Neuroinflammation and Systemic Inflammation in Alzheimer's Disease.
Hashioka S; Wu Z; Klegeris A
Curr Neuropharmacol; 2021; 19(7):908-924. PubMed ID: 33176652
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates.
Rostami J; Mothes T; Kolahdouzan M; Eriksson O; Moslem M; Bergström J; Ingelsson M; O'Callaghan P; Healy LM; Falk A; Erlandsson A
J Neuroinflammation; 2021 Jun; 18(1):124. PubMed ID: 34082772
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer's disease.
Ye M; Chung HS; Lee C; Yoon MS; Yu AR; Kim JS; Hwang DS; Shim I; Bae H
J Neuroinflammation; 2016 Jan; 13():10. PubMed ID: 26772975
[TBL] [Abstract][Full Text] [Related]
19. Immune hyperreactivity of Aβ plaque-associated microglia in Alzheimer's disease.
Yin Z; Raj D; Saiepour N; Van Dam D; Brouwer N; Holtman IR; Eggen BJL; Möller T; Tamm JA; Abdourahman A; Hol EM; Kamphuis W; Bayer TA; De Deyn PP; Boddeke E
Neurobiol Aging; 2017 Jul; 55():115-122. PubMed ID: 28434692
[TBL] [Abstract][Full Text] [Related]
20. Involvement of inflammation in Alzheimer's disease pathogenesis and therapeutic potential of anti-inflammatory agents.
Shadfar S; Hwang CJ; Lim MS; Choi DY; Hong JT
Arch Pharm Res; 2015 Dec; 38(12):2106-19. PubMed ID: 26289122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
